All stocks / PTPI
Petros Pharmaceuticals, Inc. PTPI
Petros Pharmaceuticals (PTPI): a late 10-K notice in March 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- PETROS PHARMACEUTICALS INC
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Last trade
- 09:30:39
- Website
- petrospharma.com
The financial report, and what it means
Annual figures to 2025-12-31- Net income
- $1,913,595
It earned more than it spent
SteadyAfter all costs, the company kept $1.9 million as profit in the year.
- Cash and cash equivalents
- $5,136,722
- Net cash used in operating activities
- ($6,734,707)
The cash could run out soon
Under strainIt had $5.1 million in the bank and used about $561,226 a month. At that pace the money lasts about 9 months unless it borrows or sells more shares.
- Total assets
- $5,163,598
- Total liabilities
- $2,292,744
It owns more than it owes
SteadyEverything the company owns adds up to $5.2 million. Its debts and unpaid bills add up to $2.3 million. That is about $0.44 owed for every $1 owned.
What this adds up to
1 of 3 checks show strain. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 28,043,157 shares as of 2026-08-15: 42,372,260 outstanding minus 14,329,103 held by 4 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-K on 2026-03-31: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about PTPI
Does PTPI file reports with the SEC?
Yes. Petros Pharmaceuticals files with the SEC under company number 0001815903. The most recent filing we hold is a 8-K dated 2026-09-30.
Source recordHow many PTPI shares are outstanding?
42,372,260 shares as of 2026-08-15, as reported to the SEC.
Source recordHas PTPI filed reports late?
Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-K on 2026-03-31. A notice means a report was not ready on time; check whether the report followed.
Source recordWho runs Petros Pharmaceuticals?
Officers named in its insider filings: Fady Boctor (See Remarks) and Robert Weinstein (Chief Accounting Officer).
Source recordIs Petros Pharmaceuticals making money?
After all costs, the company kept $1.9 million as profit in the year. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record